13G Filing: Acuta Capital Partners Files Update on Cas Medical Systems Inc (CASM) Position

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

SCHEDULE
13G

 

Under
the Securities Exchange Act of 1934

(Amendment
No. ________)*

 

CAS
MEDICAL SYSTEMS, INC.

(Name
of Issuer)

 

COMMON
STOCK, PAR $0.004

(Title
of Class of Securities)

 

124769209

(CUSIP
Number)

 

ACUTA
CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002

(Name,
Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

FEBRUARY
12, 2016

(Date
of Event which Requires Filing of this Statement)

 

Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[X]
Rule 13d-1(b)

[  ] Rule 13d-1(c)

[  ] Rule 13d-1(d)

 

^*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect
to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.

 

The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 124769209	13G	Page 2 of 5 Pages

1.		NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)   ACUTA CAPITAL PARTNERS LLC 45-2817402
2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) [  ] (b) [  ]
3.		SEC USE ONLY
4.		CITIZENSHIP OR PLACE OF ORGANIZATION   STATE OF DELAWARE

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.		SOLE VOTING POWER
			2,551,803
	6.		SHARED VOTING POWER
	7.		SOLE DISPOSITIVE POWER
			2,551,803
	8.		SHARED DISPOSITIVE POWER

9.		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
		2,551,803
10.		CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) [  ]
11.		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
		9.4%
12.		TYPE OF REPORTING PERSON (see instructions)
		IA

 

 

CUSIP No. 124769209	13G	Page 3 of 5 Pages

 

Item
1.

 

	(a)	Name of Issuer
		CAS MEDICAL SYSTEMS, INC.
	(b)	Address of Issuer’s Principal Executive Offices
		44 EAST INDUSTRIAL ROAD,
		BRANFORD, CT 06405

 

Item
2.

 

	(a)	Name of Person Filing
		ACUTA CAPITAL PARTNERS LLC
	(b)	Address of the Principal Office or, if none, residence
		1301 SHOREWAY ROAD, SUITE 350,
		BELMONT, CA, 94002
	(c)	Citizenship
		USA
	(d)	Title of Class of Securities
		COMMON SHARES, PAR $0.004
	(e)	CUSIP Number
		124769209

 

Item
3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is
a:

 

	(a)	[  ]	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
	(b)	[  ]	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c)	[  ]	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
	(d)	[  ]	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
	(e)	[X]	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	[  ]	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	[  ]	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
	(h)	[  ]	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	[  ]	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	[  ]	Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

 

CUSIP No. 124769209	13G	Page 4 of 5 Pages

Item
4. Ownership.

 

Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.

 

	(a)		Amount beneficially owned: 2,551,803
	(b)		Percent of class: 9.4%
	(c)		Number of shares as to which the person has:
			(i)	Sole power to vote or to direct the vote 2,551,803
			(ii)	Shared power to vote or to direct the vote 0
			(iii)	Sole power to dispose or to direct the disposition of 2,551,803
			(iv)	Shared power to dispose or to direct the disposition of 0

 

Instruction.
For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

 

Item
5. Ownership of Five Percent or Less of a Class.

 

If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following [  ].

 

Instruction.
Dissolution of a group requires a response to this item.

 

Item
6. Ownership of More than Five Percent on Behalf of Another Person.

 

Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Item
8. Identification and Classification of Members of the Group.

 

Item
9. Notice of Dissolution of Group.

 

Item
10. Certification.

 

	(a)	The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
		By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
	(b)	The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
		By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

CUSIP No. 124769209	13G	Page 5 of 5 Pages

 

After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

 

	02/12/2016
	Date
	/s/ Manfred Yu
	Signature
	Manfred Yu, CCO & COO
	Name/Title